Evotec, a leading drug discovery alliance and development partnership company, focuses on rapidly advancing innovative product approaches with top pharmaceutical and biotechnology firms. Operating worldwide, it delivers high-quality stand-alone and integrated drug discovery solutions from target-to-clinic, leveraging top-class scientific experts, state-of-the-art technologies, and deep expertise in key therapeutic areas like neuroscience, pain, metabolic diseases, oncology, and inflammation. By upgrading to IFS software, Evotec has optimized operations, setting the company up for future growth and enhancing its ability to deliver breakthrough therapies efficiently.

Join for free to read